Liver cancer cells thrive on fat, posing a serious risk of cancer diagnosis for millions of people living with fatty liver ...

Cholesterol plays a vital role in the body, providing structural support to cells and serving as a building block for hormone ...

The idea is that SYH2086 can be paired with Rezdiffra, a selective thyroid hormone receptor agonist that became the first FDA-approved drug for metabolic dysfunction-associated steatohepatitis (MASH) ...

U.S. drugmaker Madrigal Pharmaceuticals has struck a licensing deal with CSPC Pharmaceutical Group that could be worth more than $2 billion for the Chinese company if it results in a new drug for a ...

A new study from The Lancet Commission reveals that more than 60% of liver cancer cases worldwide could be prevented by targeting modifiable risk factors such as hepatitis ...

Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) (“Madrigal”) today announced that it has entered into an exclusive global license agreement with CSPC Pharmaceutical Group Limited (HKEX Stock CodeL 1093) ...

A woman from Swansea in Wales has revealed what foods she is cutting out to reverse her non-alcohol fatty liver disease (NAFD ...

Shanghai-based Zhongshan Hospital, affiliated with Fudan University, where many of the Chinese experts leading global liver ...

The majority of liver cancer cases could be prevented by reducing levels of viral hepatitis, alcohol consumption and MASLD ...

Strong efficacy and cardiovascular benefits should allow Novo to continue growing sales of GLP-1 therapies in diabetes. Ozempic and Rybelsus helped Novo gain share over Eli Lilly's once-weekly ...

Six of every 10 liver cancers diagnosed globally are preventable through reduction of risk factors, a “conservative calculation” of cases projected until 2050 has concluded.1 The Lancet commission on ...